Pfizer (PFE) Gross Profit (2009 - 2026)

Pfizer (PFE) has 18 years of Gross Profit data on file, last reported at -$1.2 billion in Q1 2026.

• Gross Profit for Q1 2026 came in at -$1.2 billion, down 65.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.7 billion (down 51.68% YoY), and the FY2025 annual result was $46.5 billion, up 591.51% from the prior year.
• Gross Profit retreated to -$1.2 billion in Q1 2026 per PFE's latest filing, from $12.3 billion in the prior quarter.
• Over five years, Gross Profit peaked at $19.1 billion in Q3 2022 and troughed at -$7.6 billion in Q4 2023.
• A 5-year average of $4.1 billion and a median of -$732.0 million in 2025 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2023 and 2024: Gross Profit slumped 146.0% in 2023, then jumped 3845.85% in 2024.
• A 5-year view of Gross Profit shows it stood at $16.6 billion in 2022, then plunged by 124.91% to -$4.1 billion in 2023, then decreased by 16.76% to -$4.8 billion in 2024, then jumped by 354.82% to $12.3 billion in 2025, then slumped by 109.84% to -$1.2 billion in 2026.
• Business Quant data shows PFE's Gross Profit at -$1.2 billion in Q1 2026, $12.3 billion in Q4 2025, and -$1.9 billion in Q3 2025.